We are ready for you, 2023! Each new year, Cardiometabolic Health Congress (CMHC) welcomes the promise of another 365.25 days in the realm of cardiovascular, cardiorenal, and cardiometabolic health. Here's what we're buzzing about in this first month of 2023!

• Our Spring 2023 conference!
• The chance to save BIG!
• Revitalizing our Advisory Board!
• Early FDA news!
• Blog mania!
• Exciting partnerships!

Did you know we've unveiled the agenda for the Spring 2023 CMHC conference? Join us for Taming the Flames: Inflammation in Cardiometabolic Disease on May 19-20, 2023, at the Gaylord Palms Resort & Convention Center in Orlando, where experts will delve into the intersection of cardiorenal metabolic disease and system inflammation. We'll discuss novel mechanisms for inflammation in hypertension, acute coronary disease, chronic kidney disease, dyslipidemia, obesity, and much more. View the full agenda

Read Where Our Worlds Collide: The Systemic Storm of Inflammation, Cardiovascular Disease and Psoriasis

We've got GOOD news and BAD news. The good news? When you purchase admittance to TWO of CMHC's upcoming 2023 conferences, you can use code BOGO50 at checkout to save 50% on the registration fee of the lower-priced event!** The bad news? Code BOGO50 expires at midnight TOMORROW, Saturday Jan. 7. Don't miss out, simply place two events in your cart, enter code BOGO50, enjoy the significant savings, and mark your 2023 calendar for CMHC's world-class conferences. Pick two and save:

Taming the Flames: Inflammation in Cardiometabolic Disease on May 19-20, 2023, at the Gaylord Palms Resort & Convention Center in Orlando. REGISTER

Women’s Cardiometabolic Health and Wellness Masterclass on Aug. 17-20, 2023, at the Laguna Cliffs Marriott Resort and Spa in Southern California. REGISTER

18th Annual Cardiometabolic Health Congress on Oct. 11-14, 2023, at the Boston Park Plaza in Downtown Boston. REGISTER

 **Code BOGO50 is valid until 11:59 p.m. on 1/7/23. One discount per customer, per transaction. Offer cannot be combined with other discounts, redeemed for cash, or applied toward previous purchases.

In November 2022, CMHC reported exciting findings in Obesity Week 2022: Semaglutide Shows Promise in Adolescents. At The Obesity Society's annual meeting the outcomes of the phase 3 STEP TEENS study were announced, indicating that adolescents with obesity benefited from a once-weekly semaglutide injection over placebo. Based on these results, Novo Nordisk just announced on Dec. 23, 2022, that the U.S. Food and Drug Administration (FDA) had expanded the label of their drug (brand name Wegovy) to include adolescents 12 years and older with obesity. Read the full story in FDA Approves Semaglutite in Pediatric Patients.

• Updated 2023 ADA Standards of Care
• Family Heart Foundation Guest Blog: Jessica's Story
• 2022 FDA-Approved Cardiometabolic Drugs and Devices
• Rising Insulin Prices: The Real Cost of Diabetes
• Research Shows Most Women Enter Pregnancy in Poor Cardiometabolic Health
• A New Era of Obesity Treatment
• Diabetes Insights and Updates with Anne L. Peters, MD
• Remembering Dr. Sarah Hallberg

At CMHC, we take women's health to heart. So does our partner organization, Women As One. In a special collaboration by women, for women across medical specialties, the RISE event was developed by Women As One to provide professional growth, access to clinical training and expert insights, and opportunities for future success. Regroup. Inspire. Strengthen. Energize. RISE.

We were thrilled to see our very own Dr. Fatima Cody Stanford - obesity medicine physician-scientist and riveting speaker at CMHC in-person and virtual events - on CBS's 60 Minutes earlier this week! Not only does Dr. Stanford lend her expertise to CMHC's provider audience, but her appearance on the national news platform 60 Minutes allowed her to reach millions of patients and health policy decision-makers regarding common misconceptions and pitfalls about the disease of obesity and its treatment.